The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Darolutamide observational (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: Second interim analysis.
 
Evan Y. Yu
Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Bayer; Janssen; Merck; Oncternal Therapeutics
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst)
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Foundation Medicine; Janssen Oncology; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen Oncology; Merck; Pfizer
 
Hiroyoshi Suzuki
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Janssen Oncology; Janssen Research & Development; Lilly; MSD K.K; Nihon Medi-Physics; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Daiichi-Sankyo; Janssen; Nippon Shinyaku; Sanofi; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Janssen (Inst); Kissei Pharmaceutical (Inst); Nihonkayaku (Inst); Takeda (Inst)
 
James L. Bailen
No Relationships to Disclose
 
Geoffrey T. Gotto
Honoraria - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen
 
Joelle P. Hamilton
Honoraria - Bayer; Janssen; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen; Novartis
Speakers' Bureau - Bayer; Janssen
Research Funding - Bayer; Janssen; Tavanta Therapeutics
 
Hiroji Uemura
Honoraria - Astellas Pharma; Bayer Yakuhin; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer Yakuhin; Janssen Oncology
 
Declan G. Murphy
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer Schering Pharma; Janssen Oncology
Travel, Accommodations, Expenses - Device Technologies
 
Thierry Lebret
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Murilo de Almeida Luz
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen; Medivation; Myovant Sciences; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche
 
Jorge A. Ortiz
Employment - Bayer
 
Patrick Adorjan
Employment - Bayer
Stock and Other Ownership Interests - Biogen
Travel, Accommodations, Expenses - Bayer
 
Javeed Khan
Employment - Bayer
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Speakers' Bureau - Astellas Pharma
Research Funding - Merck Sharp & Dohme; Sandoz-Novartis
 
Andrew J. Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Epic Sciences; Exelixis; FORMA Therapeutics; GoodRx; IDEAYA Biosciences; Janssen; Merck; Myovant Sciences; Novartis; Pfizer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); FORMA Therapeutics (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc